tiprankstipranks
Advertisement
Advertisement
Buy Rating on SL-325: Differentiated DR3 Targeting in IBD Supports Attractive Risk/Reward and $14 Price Target
PremiumRatingsBuy Rating on SL-325: Differentiated DR3 Targeting in IBD Supports Attractive Risk/Reward and $14 Price Target
1M ago
Shattuck Labs reports Q4 EPS (12c), consensus (13c)
Premium
The Fly
Shattuck Labs reports Q4 EPS (12c), consensus (13c)
1M ago
Shattuck Labs expects available cash to fund operations into 2029
Premium
The Fly
Shattuck Labs expects available cash to fund operations into 2029
1M ago
Shattuck Labs price target raised to $4 from $2 at Citi
PremiumThe FlyShattuck Labs price target raised to $4 from $2 at Citi
3M ago
Shattuck Labs upgraded to Buy from Neutral at H.C. Wainwright
Premium
The Fly
Shattuck Labs upgraded to Buy from Neutral at H.C. Wainwright
5M ago
Shattuck Labs: Hold Rating Amidst Key Milestones and Strong Financial Position
Premium
Ratings
Shattuck Labs: Hold Rating Amidst Key Milestones and Strong Financial Position
5M ago
Shattuck Labs initiated with an Outperform at Wedbush
PremiumThe FlyShattuck Labs initiated with an Outperform at Wedbush
7M ago
Shattuck Labs Closes $103M Private Placement Deal
Premium
Company Announcements
Shattuck Labs Closes $103M Private Placement Deal
8M ago
Cautious Hold on Shattuck Labs Amid Early-Stage Developments and Strategic Positioning
Premium
Ratings
Cautious Hold on Shattuck Labs Amid Early-Stage Developments and Strategic Positioning
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100